Cochlear Implants

Cochlear Implants: Basics & Indications - Hear the Future

• Surgically implanted electronic device providing functional hearing in severe-profound sensorineural hearing loss (SNHL).
• Mechanism: Bypasses damaged cochlear hair cells, directly stimulating auditory nerve fibers with electrical impulses.

⭐ Cochlear implants electrically stimulate the auditory nerve (CN VIII), bypassing damaged hair cells, offering sound perception.

• Key Indications:
  • Bilateral severe to profound SNHL; adults & children (≥9-12 months).
  • Limited benefit from optimal hearing aids (open-set sentence recognition <50-60%).
  • High patient/family motivation, realistic expectations.
  • No absolute medical/radiological contraindications (e.g., cochlear nerve aplasia, active infection). oka

Cochlear Implants: Components & Mechanism - Bionic Ear Bits

• External Components:
  • Microphone: Captures sound.
  • Speech Processor: Analyzes and digitally codes sounds.
  • Transmitter Coil: Transmits coded signals via radiofrequency to internal device; magnet holds.
• Internal Components (Surgically implanted):
  • Receiver-Stimulator: Receives signals; converts to electrical impulses.
  • Electrode Array: Thin wire with electrodes; inserted into scala tympani of cochlea, stimulates auditory nerve.
• Mechanism: Sound → Mic → Processor → Transmitter → Receiver → Electrodes → Auditory Nerve → Brain.

⭐ The electrode array is placed in the scala tympani, providing tonotopic stimulation: different electrodes stimulate nerve fibers for different sound frequencies, mimicking natural hearing.

Cochlear Implants: Candidacy Criteria - Ticket to Sound

Key for unlocking sound for severe-to-profound Sensorineural Hearing Loss (SNHL).

• Adults (≥18 yrs):
  • Bilateral severe-to-profound SNHL.
  • PTA ≥ 70 dB HL in better ear.
  • Sentence recognition ≤ 50% (best-aided).
• Children:
  • (12-24 months): Bilateral profound SNHL (PTA ≥ 90 dB HL).
  • (2-17 years): Bilateral severe-to-profound SNHL (PTA ≥ 70 dB HL).
  • Limited hearing aid benefit; poor auditory skill development.
• General: No medical/radiological contraindications; realistic expectations; strong support system.

⭐ A trial with appropriately fitted hearing aids for at least 3-6 months is usually required before CI consideration.

Cochlear Implants: Surgical Procedure & Complications - Scalpel & Soundwaves

• Surgical Steps:
  • Standard post-auricular incision; cortical mastoidectomy.
  • Facial recess approach (posterior tympanotomy) to access middle ear.
  • Electrode insertion via cochleostomy or Round Window (RW).
• Insertion Techniques:
  • Round Window: Preferred, less traumatic, aims for hearing preservation.
  • Cochleostomy: Drilled antero-inferior to RW.
• Potential Complications:
  • Intra-op: Facial nerve injury (⚠️ crucial monitoring), CSF leak, perilymph gusher, bleeding.
  • Post-op (Early): Wound infection, hematoma, flap necrosis, vertigo, tinnitus, device displacement.
  • Post-op (Late): Device failure, electrode migration, meningitis (vaccination important!), fibrous tissue (impedance ↑).

⭐ Facial nerve integrity is paramount; intraoperative monitoring (e.g., NIM) is standard of care to prevent injury. oka

Cochlear Implants: Post-op & Outcomes - New Soundscapes

• Post-operative Phase:
  • Routine wound care.
  • Device activation: 2-4 weeks after surgery.
• Device Programming (Mapping):
  • Speech processor customized.
  • Electrical stimulation thresholds (T-levels) and comfort levels (C-levels) set for each electrode.
  • Periodic adjustments essential.
• Auditory Rehabilitation:
  • Critical for maximizing benefit; trains brain to interpret new signals.
  • Involves intensive speech therapy and listening exercises.
• Expected Outcomes:
  • Significant improvement in sound detection and speech understanding (open-set).
  • Enhanced speech production.

  ⭐ Early implantation in pre-lingually deaf children (ideally < 2 years) significantly improves speech and language acquisition trajectories.

High‑Yield Points - ⚡ Biggest Takeaways

• Bilateral severe-to-profound SNHL is the main indication for cochlear implantation.
• Candidates show limited benefit from appropriately fitted hearing aids.
• Minimum age is generally 12 months, earlier in post-meningitic deafness.
• Patent cochlea is essential; internal device has electrode array in scala tympani.
• External components include microphone, speech processor, and transmitter coil.
• Post-operative Neural Response Telemetry (NRT) and mapping are crucial.
• Intensive auditory-verbal therapy is vital for optimal outcomes and speech development.